An inducible mouse model for PAX2-dependent glomerular disease: Insights into a complex pathogenesis

被引:35
作者
Wagner, KD
Wagner, N
Guo, JK
Eiger, M
Dallman, MJ
Bugeon, L
Schedl, A [1 ]
机构
[1] INSERM, U636, F-06108 Nice, France
[2] Univ Nice, Ctr Biochim, Fac Sci, F-06108 Nice, France
[3] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA
[4] Heidelberg Univ, Inst Anat & Cell Biol 1, D-69120 Heidelberg, Germany
[5] Imperial Coll London, CMMI Biol Sci, London SW7 2AZ, England
关键词
D O I
10.1016/j.cub.2006.02.072
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pax2 is a transcription factor with important functions during kidney development [1-3]. Ectopic expression of Pax2 in podocytes has been reported in various glomerular diseases [4-7], but the functional relevance remains unknown. We developed an inducible mouse model that allows activation of Pax2 specifically in podocytes. Persistent expression of Pax2 did not interfere with the initial differentiation of podocytes, but mice ectopically expressing PAX2 developed end-stage renal failure soon after birth. Similarly, activation of PAX2 in healthy adult animals resulted in renal disease within 3 weeks after podocyte-specific induction of a deleter Cre. PAX2 activation caused repression of the podocyte key regulator molecule Wt1 and consequently a dramatic reduction of nephrin expression. Recruitment of the groucho-related protein TLE4 may be involved in converting Pax2 into a transcriptional repressor of Wt1. Finally, treatment of mice with an angiotensin-converting enzyme (ACE) inhibitor normalized renal function and induced upregulation of the important structural molecule nephrin via a Wt1-independent pathway. Our data demonstrate the functional significance of PAX2 reexpression in mature podocytes for the development of glomerular diseases and suggest that reactivation of PAX genes in terminally differentiated cells leads to a more dedifferentiated phenotype.
引用
收藏
页码:793 / 800
页数:8
相关论文
共 33 条
[1]   Alternatively used promoters and distinct elements direct tissue-specific expression of nephrin [J].
Beltcheva, O ;
Kontusaari, S ;
Fetissov, S ;
Putaala, H ;
Kilpeläinen, P ;
Hökfelt, T ;
Tryggvason, K .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (02) :352-358
[2]  
Benigni A, 2001, J AM SOC NEPHROL, V12, P941, DOI 10.1681/ASN.V125941
[3]   The secreted frizzled related protein 2 (SFRP2) gene is a target of the Pax2 transcription factor [J].
Brophy, PD ;
Lang, KM ;
Dressler, GR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (52) :52401-52405
[4]  
Brophy PD, 2001, DEVELOPMENT, V128, P4747
[5]   Inducible gene silencing in podocytes: A new tool for studying glomerular function [J].
Bugeon, L ;
Danou, A ;
Carpentier, D ;
Langridge, P ;
Syed, N ;
Dallman, MJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (03) :786-791
[6]  
Burns GC, 1997, J AM SOC NEPHROL, V8, P1140
[7]   Groucho suppresses Pax2 transactivation by inhibition of JNK-mediated phosphorylation [J].
Cai, Y ;
Brophy, PD ;
Levitan, I ;
Stifani, S ;
Dressler, GR .
EMBO JOURNAL, 2003, 22 (20) :5522-5529
[8]   Angiotensin inhibition reduces glomerular damage and renal chemokine expression in MRL/lpr mice [J].
De Lema, GP ;
De Wit, C ;
Cohen, CD ;
Nieto, E ;
Molina, A ;
Banas, B ;
Luckow, B ;
Vicente, AB ;
Mampaso, F ;
Schlöndorff, D .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (01) :275-281
[9]  
Dehbi M, 1996, ONCOGENE, V13, P447
[10]   DEREGULATION OF PAX-2 EXPRESSION IN TRANSGENIC MICE GENERATES SEVERE KIDNEY ABNORMALITIES [J].
DRESSLER, GR ;
WILKINSON, JE ;
ROTHENPIELER, UW ;
PATTERSON, LT ;
WILLIAMSSIMONS, L ;
WESTPHAL, H .
NATURE, 1993, 362 (6415) :65-67